College of Medicine
Haller Type 1 Diabetes Research Group
Led by Michael J Haller · Pediatrics
What we study
Dr. Haller's lab studies type 1 diabetes, focusing on predicting, preventing, and reversing it through clinical trials and technology studies. They use immunotherapies, pumps, and glucose monitors to improve diabetes management.
What working here is like
- Clinical
- Human participants
- Projects
- 5
- Papers
- 5
Current projects
PRISE-hATG
A study on preserving endogenous CPeptide in type 1 diabetes patients treated with human anti-thymocyte globulin.
Data Coordinating Center for Type 1 Diabetes TrialNet
A project supporting clinical trials for type 1 diabetes through data coordination.
Show 3 more projectsShow fewer
A Non-Interventional Study of HLA-DRB1*04:01 Distribution in Adults With Recently Diagnosed Type 1 Diabetes (T1D)
Research on the genetic marker HLA-DRB1*04:01 in newly diagnosed type 1 diabetes patients.
Implementation of Early Stage T1D Education and Support (ESTES)
A program to improve education and support for children with type 1 diabetes.
A Multicenter, Multinational Extension of Study PRV-031-001 to Evaluate the Long-Term Safety of Teplizumab
A study on the safety of teplizumab, an anti-CD3 monoclonal antibody, in children with type 1 diabetes.
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
Recent papers, explained
- Identification of a type 1 diabetes–associated T cell receptor repertoire signature from the human peripheral blood
2026 · Science Advances
Finds that immune cells in type 1 diabetes patients have distinct genetic markers.
- Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada
2026 · Diabetes Care
Compares costs and benefits of screening everyone vs. high-risk groups for type 1 diabetes in Canada.
Show 3 more papersShow fewer
- Low-Dose Antithymocyte Globulin in Type 1 Diabetes: Real-World Exploratory Observation of C-Peptide by Modified Quantitative Response (mQR)
2026 · Diabetes Care
Explores whether low-dose antithymocyte globulin improves C-peptide levels in type 1 diabetes patients.
- Characterizing glycemic control and technology use among insulin-requiring patients at federally qualified health centers: a cross-sectional study
2026 · BMC Endocrine Disorders
Describes how insulin-requiring diabetes patients at health centers manage their blood sugar and use technology.
- Screening for Early-Stage Type 1 Diabetes in Children
2026 · JAMA
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Michael J Haller hasn't set up this page yet. Their UF Scholars profile lists their publications.